MAYNE PHARMA GROUP LIMITED — Capital/Financing Update 2012

Dec 13, 2012

Manager, Company Announcements ASX Limited Rialto Towers Level 45, 525 Collins Street MELBOURNE VIC 3000

14 December 2012

Via E-Lodgement

Dear Sir/Madam

Mayne Pharma Group Limited - Request for Trading Halt

The directors of Mayne Pharma Group Limited ACN 115 832 963 (ASX: MYX) (Mayne Pharma) request a trading halt from the commencement of trading on 14 December 2012 at which time Mayne Pharma proposes to announce an institutional placement in order to fund an acquisition.

For the purposes of ASX Listing Rule 17.1, Mayne Pharma provides the following further information:

• $(a)$ Mayne Pharma expects that the trading halt remain in place until the commencement of trading on 17 December 2012, unless, before that time, Mayne Pharma requests that the trading halt be lifted; and
• $(b)$ Mayne Pharma is not aware of any reason why the trading halt should not be granted.

If you have any queries, please do not hesitate to contact the writer.

Yours Sincerely

Mark Cansdale Chief Financial Officer and Company Secretary

t | +61 3 8614 7777 f | +61 3 9614 7022 | www.maynepharma.com